The Food and Drug Administration Center for Biologics Evaluation and Research vaccine division was led by a former head of vaccine development at Merck

Overview Debates Related claims Topics

Under Attorney General Ken Paxton, the Texas Attorney General's office filed legal challenges against DACA and the sale of mifepristone

An Environmental Protection Agency assessment on glyphosate safety was discarded in court after evidence showed chemical company Bayer ghostwrote research sections

Moderna developed an mRNA-based influenza vaccine candidate in a joint investment venture with Blackstone

Department of Justice attorney Sarah Harris, previously employed at Bayer's primary law firm, drafted the brief supporting glyphosate liability protection before the Supreme Court

The federal standard for 7-hydroxymitragynine in kratom products was initially recommended at a concentration cap of 0.05 percent

Clinical trials for Moderna's mRNA influenza vaccine demonstrated an absolute risk reduction rate of 0.8 percent

Food and Drug Administration Commissioner Marty Makary was dismissed from office after resisting efforts to ease approval standards for fruit-flavored e-cigarettes

The concentration allowance for the opioid alkaloid 7-hydroxymitragynine in retail kratom products was raised twentyfold above initial recommendations

Federal regulations require safety studies demonstrating a lack of harm to minors prior to Food and Drug Administration approval of vaping products

The American Heart Association filed a lawsuit against the Food and Drug Administration challenging relaxed standards on fruit-flavored vaping products

The United States Department of Health and Human Services compounding peptide policy includes requirements regarding registered manufacturing facilities, certificates of analysis, and labeling

The United States Department of Health and Human Services announced an enforcement policy covering six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500

The United States Department of Health and Human Services compounding peptide policy restricts the combination of multiple active peptides into a single compounded product

Under specific conditions, the United States Department of Health and Human Services does not intend to take enforcement action against certain peptide compounders while an FDA formal evaluation process continues

Restricting sleep to four hours per night significantly reduces human antibody production in response to vaccines

The introduction of mRNA vaccines during the COVID-19 pandemic established rapid-response platform technologies capable of generating infectious disease countermeasures shortly after genomic sequencing

Routine childhood vaccinations against smallpox in the United States were discontinued in 1972

Restricting human sleep to four hours per night from 1:00 AM to 5:00 AM significantly reduces antibody production following vaccination

In 1721, Cotton Mather and Dr. Zabdiel Boylston introduced smallpox variolation to Boston during an outbreak

The 19th-century Leicester Method in England controlled smallpox outbreaks through strict patient quarantine and sanitary measures without mass vaccination